Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. NVDA
6. ROIV
7. CRCL
8. AAPL
9. V
10. HOOD

Go back to Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in ER-Positive Breast Cancer
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.55 +0.03 (1.19%)
Previous Close $2.52    52 Week High $3.64 
Open $2.49    52 Week Low $0.14 
Day High $2.59    P/E N/A 
Day Low $2.44    EPS $0.00 
Volume 10,535